Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosis.
Ann Hematol
; 101(4): 929-931, 2022 04.
Article
in English
| MEDLINE | ID: covidwho-1321736
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Primary Myelofibrosis
/
COVID-19
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Ann Hematol
Journal subject:
Hematology
Year:
2022
Document Type:
Article
Affiliation country:
S00277-021-04613-w
Similar
MEDLINE
...
LILACS
LIS